Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults

NCT00473967 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Occurrence of unacceptable adverse events.

Conditions

Hookworm Infection

Interventions

BIOLOGICAL: Na-ASP-2 Hookworm Vaccine

Sponsor

Albert B. Sabin Vaccine Institute

Collaborators

[object Object]
[object Object]
[object Object]